BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18940601)

  • 1. Chaperone-assisted crystallography with DARPins.
    Sennhauser G; Grütter MG
    Structure; 2008 Oct; 16(10):1443-53. PubMed ID: 18940601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DARPin-Based Crystallization Chaperones Exploit Molecular Geometry as a Screening Dimension in Protein Crystallography.
    Batyuk A; Wu Y; Honegger A; Heberling MM; Plückthun A
    J Mol Biol; 2016 Apr; 428(8):1574-88. PubMed ID: 26975886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of wild-type Plk-1 kinase domain in complex with a selective DARPin.
    Bandeiras TM; Hillig RC; Matias PM; Eberspaecher U; Fanghänel J; Thomaz M; Miranda S; Crusius K; Pütter V; Amstutz P; Gulotti-Georgieva M; Binz HK; Holz C; Schmitz AA; Lang C; Donner P; Egner U; Carrondo MA; Müller-Tiemann B
    Acta Crystallogr D Biol Crystallogr; 2008 Apr; 64(Pt 4):339-53. PubMed ID: 18391401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A designed ankyrin repeat protein evolved to picomolar affinity to Her2.
    Zahnd C; Wyler E; Schwenk JM; Steiner D; Lawrence MC; McKern NM; Pecorari F; Ward CW; Joos TO; Plückthun A
    J Mol Biol; 2007 Jun; 369(4):1015-28. PubMed ID: 17466328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designed ankyrin repeat protein binders for the crystallization of AcrB: plasticity of the dominant interface.
    Monroe N; Sennhauser G; Seeger MA; Briand C; Grütter MG
    J Struct Biol; 2011 May; 174(2):269-81. PubMed ID: 21296164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilizing ionic interactions in a full-consensus ankyrin repeat protein.
    Merz T; Wetzel SK; Firbank S; Plückthun A; Grütter MG; Mittl PR
    J Mol Biol; 2008 Feb; 376(1):232-40. PubMed ID: 18155045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants for improved stability of designed ankyrin repeat proteins with a redesigned C-capping module.
    Kramer MA; Wetzel SK; Plückthun A; Mittl PR; Grütter MG
    J Mol Biol; 2010 Dec; 404(3):381-91. PubMed ID: 20851127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma.
    Kumar A; Mandiyan V; Suzuki Y; Zhang C; Rice J; Tsai J; Artis DR; Ibrahim P; Bremer R
    J Mol Biol; 2005 Apr; 348(1):183-93. PubMed ID: 15808862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection and characterization of DARPins and Fab fragments for the co-crystallization of membrane proteins: The Na(+)-citrate symporter CitS as an example.
    Huber T; Steiner D; Röthlisberger D; Plückthun A
    J Struct Biol; 2007 Aug; 159(2):206-21. PubMed ID: 17369048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric inhibition of aminoglycoside phosphotransferase by a designed ankyrin repeat protein.
    Kohl A; Amstutz P; Parizek P; Binz HK; Briand C; Capitani G; Forrer P; Plückthun A; Grütter MG
    Structure; 2005 Aug; 13(8):1131-41. PubMed ID: 16084385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designed ankyrin repeat proteins (DARPins) from research to therapy.
    Tamaskovic R; Simon M; Stefan N; Schwill M; Plückthun A
    Methods Enzymol; 2012; 503():101-34. PubMed ID: 22230567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of the wild-type and activated catalytic domains of Brachydanio rerio Polo-like kinase 1 (Plk1): changes in the active-site conformation and interactions with ligands.
    Elling RA; Fucini RV; Romanowski MJ
    Acta Crystallogr D Biol Crystallogr; 2008 Sep; 64(Pt 9):909-18. PubMed ID: 18703838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From DARPins to LoopDARPins: novel LoopDARPin design allows the selection of low picomolar binders in a single round of ribosome display.
    Schilling J; Schöppe J; Plückthun A
    J Mol Biol; 2014 Feb; 426(3):691-721. PubMed ID: 24513107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DARPins: a true alternative to antibodies.
    Stumpp MT; Amstutz P
    Curr Opin Drug Discov Devel; 2007 Mar; 10(2):153-9. PubMed ID: 17436550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge-based design of reagentless fluorescent biosensors from a designed ankyrin repeat protein.
    Brient-Litzler E; Plückthun A; Bedouelle H
    Protein Eng Des Sel; 2010 Apr; 23(4):229-41. PubMed ID: 19945965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
    Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
    J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 50 kilodalton protein associated with raf and pp60(v-src) protein kinases is a mammalian homolog of the cell cycle control protein cdc37.
    Perdew GH; Wiegand H; Vanden Heuvel JP; Mitchell C; Singh SS
    Biochemistry; 1997 Mar; 36(12):3600-7. PubMed ID: 9132011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MBP-binding DARPins facilitate the crystallization of an MBP fusion protein.
    Gumpena R; Lountos GT; Waugh DS
    Acta Crystallogr F Struct Biol Commun; 2018 Sep; 74(Pt 9):549-557. PubMed ID: 30198887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
    Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
    J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific targeting of human caspases using designed ankyrin repeat proteins.
    Flütsch A; Schroeder T; Barandun J; Ackermann R; Bühlmann M; Grütter MG
    Biol Chem; 2014 Oct; 395(10):1243-52. PubMed ID: 25153593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.